vs

Side-by-side financial comparison of Community West Bancshares (CWBC) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

Community West Bancshares is the larger business by last-quarter revenue ($38.3M vs $32.6M, roughly 1.2× RxSight, Inc.). On growth, Community West Bancshares posted the faster year-over-year revenue change (11.6% vs -18.9%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $-2.3M). Over the past eight quarters, Community West Bancshares's revenue compounded faster (36.0% CAGR vs 5.1%).

Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

CWBC vs RXST — Head-to-Head

Bigger by revenue
CWBC
CWBC
1.2× larger
CWBC
$38.3M
$32.6M
RXST
Growing faster (revenue YoY)
CWBC
CWBC
+30.5% gap
CWBC
11.6%
-18.9%
RXST
More free cash flow
CWBC
CWBC
$45.9M more FCF
CWBC
$43.6M
$-2.3M
RXST
Faster 2-yr revenue CAGR
CWBC
CWBC
Annualised
CWBC
36.0%
5.1%
RXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CWBC
CWBC
RXST
RXST
Revenue
$38.3M
$32.6M
Net Profit
$-9.2M
Gross Margin
77.5%
Operating Margin
40.0%
-34.8%
Net Margin
-28.1%
Revenue YoY
11.6%
-18.9%
Net Profit YoY
-54.1%
EPS (diluted)
$0.58
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWBC
CWBC
RXST
RXST
Q4 25
$38.3M
$32.6M
Q3 25
$37.9M
$30.3M
Q2 25
$35.7M
$33.6M
Q1 25
$34.8M
$37.9M
Q4 24
$34.3M
$40.2M
Q3 24
$31.3M
$35.3M
Q2 24
$30.5M
$34.9M
Q1 24
$20.7M
$29.5M
Net Profit
CWBC
CWBC
RXST
RXST
Q4 25
$-9.2M
Q3 25
$10.9M
$-9.8M
Q2 25
$7.8M
$-11.8M
Q1 25
$8.3M
$-8.2M
Q4 24
$-5.9M
Q3 24
$3.4M
$-6.3M
Q2 24
$-6.3M
$-6.1M
Q1 24
$3.7M
$-9.1M
Gross Margin
CWBC
CWBC
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
CWBC
CWBC
RXST
RXST
Q4 25
40.0%
-34.8%
Q3 25
39.8%
-40.1%
Q2 25
30.2%
-41.6%
Q1 25
32.7%
-28.2%
Q4 24
31.0%
-21.5%
Q3 24
13.3%
-26.1%
Q2 24
-25.9%
-23.9%
Q1 24
23.2%
-36.2%
Net Margin
CWBC
CWBC
RXST
RXST
Q4 25
-28.1%
Q3 25
28.7%
-32.4%
Q2 25
22.0%
-35.0%
Q1 25
23.8%
-21.6%
Q4 24
-14.8%
Q3 24
10.8%
-17.9%
Q2 24
-20.7%
-17.4%
Q1 24
17.8%
-30.8%
EPS (diluted)
CWBC
CWBC
RXST
RXST
Q4 25
$0.58
$-0.22
Q3 25
$0.57
$-0.24
Q2 25
$0.41
$-0.29
Q1 25
$0.44
$-0.20
Q4 24
$0.29
$-0.14
Q3 24
$0.18
$-0.16
Q2 24
$-0.33
$-0.16
Q1 24
$0.31
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWBC
CWBC
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$119.0M
$228.1M
Total DebtLower is stronger
$69.5M
Stockholders' EquityBook value
$409.6M
$275.7M
Total Assets
$3.7B
$311.8M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWBC
CWBC
RXST
RXST
Q4 25
$119.0M
$228.1M
Q3 25
$121.6M
$227.5M
Q2 25
$134.4M
$227.5M
Q1 25
$148.4M
$229.3M
Q4 24
$120.4M
$237.2M
Q3 24
$149.0M
$237.1M
Q2 24
$109.7M
$233.3M
Q1 24
$61.0M
$125.4M
Total Debt
CWBC
CWBC
RXST
RXST
Q4 25
$69.5M
Q3 25
Q2 25
Q1 25
Q4 24
$69.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CWBC
CWBC
RXST
RXST
Q4 25
$409.6M
$275.7M
Q3 25
$397.6M
$276.0M
Q2 25
$380.0M
$278.0M
Q1 25
$372.2M
$279.3M
Q4 24
$362.7M
$281.2M
Q3 24
$363.5M
$277.3M
Q2 24
$350.2M
$275.2M
Q1 24
$211.7M
$163.9M
Total Assets
CWBC
CWBC
RXST
RXST
Q4 25
$3.7B
$311.8M
Q3 25
$3.6B
$308.5M
Q2 25
$3.6B
$309.0M
Q1 25
$3.6B
$313.0M
Q4 24
$3.5B
$318.6M
Q3 24
$3.5B
$310.5M
Q2 24
$3.5B
$305.5M
Q1 24
$2.4B
$183.2M
Debt / Equity
CWBC
CWBC
RXST
RXST
Q4 25
0.17×
Q3 25
Q2 25
Q1 25
Q4 24
0.19×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWBC
CWBC
RXST
RXST
Operating Cash FlowLast quarter
$46.1M
$-1.1M
Free Cash FlowOCF − Capex
$43.6M
$-2.3M
FCF MarginFCF / Revenue
113.9%
-6.9%
Capex IntensityCapex / Revenue
6.6%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$77.7M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWBC
CWBC
RXST
RXST
Q4 25
$46.1M
$-1.1M
Q3 25
$13.2M
$-1.2M
Q2 25
$11.5M
$-4.4M
Q1 25
$11.1M
$-8.8M
Q4 24
$22.2M
$-4.3M
Q3 24
$7.8M
$650.0K
Q2 24
$5.2M
$-4.0M
Q1 24
$4.0M
$-9.3M
Free Cash Flow
CWBC
CWBC
RXST
RXST
Q4 25
$43.6M
$-2.3M
Q3 25
$12.8M
$-1.8M
Q2 25
$10.6M
$-5.9M
Q1 25
$10.8M
$-9.4M
Q4 24
$17.2M
$-5.1M
Q3 24
$5.2M
$-453.0K
Q2 24
$4.8M
$-5.5M
Q1 24
$3.6M
$-11.3M
FCF Margin
CWBC
CWBC
RXST
RXST
Q4 25
113.9%
-6.9%
Q3 25
33.7%
-5.8%
Q2 25
29.6%
-17.6%
Q1 25
30.9%
-24.8%
Q4 24
50.0%
-12.7%
Q3 24
16.7%
-1.3%
Q2 24
15.7%
-15.9%
Q1 24
17.3%
-38.2%
Capex Intensity
CWBC
CWBC
RXST
RXST
Q4 25
6.6%
3.5%
Q3 25
1.1%
1.9%
Q2 25
2.7%
4.6%
Q1 25
0.9%
1.5%
Q4 24
14.7%
2.1%
Q3 24
8.1%
3.1%
Q2 24
1.4%
4.4%
Q1 24
2.1%
6.7%
Cash Conversion
CWBC
CWBC
RXST
RXST
Q4 25
Q3 25
1.21×
Q2 25
1.47×
Q1 25
1.33×
Q4 24
Q3 24
2.29×
Q2 24
Q1 24
1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CWBC
CWBC

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons